Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00039052
Status:
COMPLETED
Last Update Posted:
2013-07-18
First Post:
2002-06-06
Brief Title:
Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer Non-Small Cell Lung Cancer or Breast Cancer
Sponsor:
Neurocrine Biosciences
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
NBI-3001-ST-0101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Neurocrine Biosciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None